Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 31 | 2025 | 377 | 4.590 |
Why?
|
| Respiratory Syncytial Virus, Human | 27 | 2025 | 233 | 4.570 |
Why?
|
| Viral Load | 9 | 2025 | 411 | 1.860 |
Why?
|
| Respiratory Tract Infections | 7 | 2025 | 296 | 1.070 |
Why?
|
| Organoids | 3 | 2025 | 299 | 0.940 |
Why?
|
| Respiratory Syncytial Viruses | 5 | 2025 | 153 | 0.910 |
Why?
|
| RNA, Viral | 8 | 2024 | 562 | 0.880 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 68 | 0.880 |
Why?
|
| Virus Replication | 6 | 2025 | 634 | 0.840 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 6 | 2025 | 71 | 0.830 |
Why?
|
| Viral Fusion Proteins | 9 | 2023 | 76 | 0.800 |
Why?
|
| Antibodies, Viral | 14 | 2025 | 1205 | 0.750 |
Why?
|
| Bacterial Adhesion | 3 | 2007 | 106 | 0.740 |
Why?
|
| Picornaviridae Infections | 4 | 2025 | 52 | 0.730 |
Why?
|
| Transplant Recipients | 3 | 2021 | 227 | 0.680 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 98 | 0.620 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 136 | 0.610 |
Why?
|
| Cytokines | 2 | 2024 | 1378 | 0.600 |
Why?
|
| Influenza, Human | 7 | 2024 | 700 | 0.560 |
Why?
|
| Bronchiolitis | 4 | 2021 | 123 | 0.520 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 1191 | 0.520 |
Why?
|
| Genome, Viral | 4 | 2025 | 184 | 0.500 |
Why?
|
| Virus Diseases | 4 | 2022 | 291 | 0.490 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 265 | 0.490 |
Why?
|
| Hospitalization | 9 | 2025 | 1921 | 0.440 |
Why?
|
| Epithelial Cells | 4 | 2024 | 932 | 0.430 |
Why?
|
| Immunity, Innate | 4 | 2025 | 415 | 0.400 |
Why?
|
| Rhinovirus | 3 | 2025 | 63 | 0.400 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 49 | 0.380 |
Why?
|
| Antibodies, Neutralizing | 7 | 2023 | 498 | 0.370 |
Why?
|
| Viruses | 3 | 2024 | 128 | 0.360 |
Why?
|
| Humans | 63 | 2025 | 133373 | 0.360 |
Why?
|
| Phenotype | 1 | 2021 | 4577 | 0.350 |
Why?
|
| Seasons | 5 | 2024 | 328 | 0.350 |
Why?
|
| Genotype | 8 | 2025 | 2720 | 0.340 |
Why?
|
| Influenza A virus | 2 | 2015 | 152 | 0.340 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 75 | 0.340 |
Why?
|
| Sindbis Virus | 1 | 2009 | 10 | 0.320 |
Why?
|
| Infant | 18 | 2025 | 13243 | 0.320 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2022 | 179 | 0.320 |
Why?
|
| Adult | 18 | 2025 | 31684 | 0.310 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 545 | 0.300 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 130 | 0.300 |
Why?
|
| Virus Shedding | 4 | 2021 | 82 | 0.300 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 380 | 0.280 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 771 | 0.270 |
Why?
|
| Female | 27 | 2025 | 71503 | 0.260 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2006 | 12 | 0.250 |
Why?
|
| Nucleosides | 1 | 2025 | 19 | 0.240 |
Why?
|
| Male | 22 | 2025 | 65592 | 0.230 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.230 |
Why?
|
| Immunity, Mucosal | 2 | 2025 | 94 | 0.230 |
Why?
|
| Adenovirus Infections, Human | 1 | 2025 | 57 | 0.230 |
Why?
|
| Adenoviruses, Human | 1 | 2025 | 99 | 0.230 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 498 | 0.230 |
Why?
|
| Nose | 1 | 2025 | 105 | 0.230 |
Why?
|
| Texas | 5 | 2023 | 3666 | 0.220 |
Why?
|
| Antigens, Viral | 3 | 2024 | 438 | 0.220 |
Why?
|
| Genetic Variation | 4 | 2025 | 1597 | 0.220 |
Why?
|
| Liposomes | 1 | 2025 | 207 | 0.220 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 14 | 0.210 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 215 | 0.210 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 790 | 0.210 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 62 | 0.210 |
Why?
|
| Antiviral Agents | 3 | 2025 | 824 | 0.210 |
Why?
|
| Acetamides | 1 | 2024 | 51 | 0.210 |
Why?
|
| Pandemics | 6 | 2024 | 1193 | 0.210 |
Why?
|
| Enterovirus | 1 | 2024 | 51 | 0.210 |
Why?
|
| Poliovirus | 1 | 2023 | 48 | 0.210 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 330 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2006 | 910 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 294 | 0.200 |
Why?
|
| Phylogeny | 5 | 2025 | 781 | 0.200 |
Why?
|
| Child, Preschool | 13 | 2025 | 14873 | 0.200 |
Why?
|
| Cell Line | 5 | 2023 | 2853 | 0.190 |
Why?
|
| Lung | 3 | 2025 | 1571 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 357 | 0.190 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 11 | 0.190 |
Why?
|
| Palivizumab | 2 | 2021 | 48 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 359 | 0.180 |
Why?
|
| Coinfection | 2 | 2021 | 182 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 81 | 0.180 |
Why?
|
| Viral Structural Proteins | 1 | 2021 | 47 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 348 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1830 | 0.170 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 45 | 0.170 |
Why?
|
| Child | 15 | 2025 | 25868 | 0.170 |
Why?
|
| Prospective Studies | 8 | 2025 | 6582 | 0.170 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 71 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1513 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 356 | 0.170 |
Why?
|
| Middle Aged | 7 | 2025 | 28985 | 0.160 |
Why?
|
| Haemophilus | 1 | 2019 | 14 | 0.160 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 155 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2021 | 416 | 0.150 |
Why?
|
| Cities | 3 | 2024 | 51 | 0.150 |
Why?
|
| Orthomyxoviridae | 1 | 2019 | 52 | 0.150 |
Why?
|
| Adolescent | 9 | 2025 | 20573 | 0.150 |
Why?
|
| Laboratories | 1 | 2019 | 89 | 0.150 |
Why?
|
| Young Adult | 5 | 2021 | 9923 | 0.140 |
Why?
|
| Cross Infection | 1 | 2021 | 344 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| Genes, Viral | 1 | 2017 | 185 | 0.130 |
Why?
|
| CHO Cells | 2 | 2007 | 167 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 553 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 491 | 0.130 |
Why?
|
| Cricetinae | 2 | 2007 | 395 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2019 | 329 | 0.120 |
Why?
|
| Vaccination | 2 | 2023 | 1019 | 0.120 |
Why?
|
| Influenza B virus | 1 | 2015 | 100 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.120 |
Why?
|
| United States | 7 | 2025 | 11722 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2877 | 0.110 |
Why?
|
| Bodily Secretions | 1 | 2014 | 7 | 0.110 |
Why?
|
| Nasopharynx | 3 | 2019 | 87 | 0.110 |
Why?
|
| Mutation | 2 | 2024 | 6343 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 67 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1757 | 0.110 |
Why?
|
| Animals | 9 | 2025 | 36222 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 189 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2785 | 0.110 |
Why?
|
| Microbiota | 1 | 2019 | 443 | 0.110 |
Why?
|
| Aged | 5 | 2021 | 21500 | 0.110 |
Why?
|
| Caspases | 1 | 2014 | 166 | 0.110 |
Why?
|
| Alphavirus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 631 | 0.100 |
Why?
|
| Sigmodontinae | 2 | 2025 | 44 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 39 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8632 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 305 | 0.100 |
Why?
|
| Acute Disease | 2 | 2025 | 1184 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 7141 | 0.090 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 63 | 0.090 |
Why?
|
| Cattle | 2 | 2024 | 588 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2021 | 273 | 0.090 |
Why?
|
| Insect Viruses | 1 | 2009 | 9 | 0.080 |
Why?
|
| Organisms, Genetically Modified | 1 | 2009 | 11 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 1583 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2009 | 22 | 0.080 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 96 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3960 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3740 | 0.080 |
Why?
|
| Molecular Typing | 2 | 2021 | 34 | 0.070 |
Why?
|
| Drosophila | 1 | 2013 | 828 | 0.070 |
Why?
|
| Virulence | 2 | 2006 | 278 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2006 | 116 | 0.070 |
Why?
|
| Cricetulus | 1 | 2007 | 97 | 0.070 |
Why?
|
| Islam | 1 | 2006 | 12 | 0.060 |
Why?
|
| Arabs | 1 | 2006 | 30 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 52 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2006 | 1136 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 30 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 77 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 873 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 98 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2025 | 50 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 276 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 138 | 0.060 |
Why?
|
| Livestock | 1 | 2024 | 12 | 0.060 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 545 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 240 | 0.060 |
Why?
|
| Age Factors | 2 | 2025 | 2956 | 0.060 |
Why?
|
| Influenza in Birds | 1 | 2024 | 30 | 0.060 |
Why?
|
| Adenosine | 1 | 2025 | 140 | 0.060 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 63 | 0.050 |
Why?
|
| Birds | 1 | 2024 | 87 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 20 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2024 | 72 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2006 | 441 | 0.050 |
Why?
|
| Transfection | 1 | 2006 | 1095 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 844 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2006 | 815 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 315 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2003 | 41 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1915 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1852 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 391 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 719 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 75 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 393 | 0.050 |
Why?
|
| Pregnancy | 3 | 2022 | 7602 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 33 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2025 | 1083 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3418 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 27 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 123 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2142 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 130 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 366 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2022 | 49 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 50 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 199 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2021 | 54 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2025 | 289 | 0.050 |
Why?
|
| Turbinates | 1 | 2021 | 12 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2022 | 29 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 401 | 0.050 |
Why?
|
| Water | 1 | 2023 | 199 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 39 | 0.050 |
Why?
|
| Fever | 1 | 2024 | 312 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 424 | 0.040 |
Why?
|
| Species Specificity | 1 | 2022 | 563 | 0.040 |
Why?
|
| Gene Expression | 1 | 2006 | 1608 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 220 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 147 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 283 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 470 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 707 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 3043 | 0.040 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2020 | 10 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2020 | 41 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 3105 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3131 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 42 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 162 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 753 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 275 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 151 | 0.040 |
Why?
|
| DNA Probes | 1 | 2019 | 124 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 87 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 77 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 184 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6544 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 795 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 824 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1323 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1135 | 0.040 |
Why?
|
| DNA Primers | 1 | 2019 | 656 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 199 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3794 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 863 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2559 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1325 | 0.030 |
Why?
|
| Chile | 1 | 2017 | 27 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 42 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1469 | 0.030 |
Why?
|
| Genomics | 1 | 2025 | 1676 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1473 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 76 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 94 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 361 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 415 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 252 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2015 | 52 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 148 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 144 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 537 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 637 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4760 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5199 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3395 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 238 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1049 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3718 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1166 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2288 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3988 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 18936 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 125 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 125 | 0.020 |
Why?
|
| India | 1 | 2006 | 239 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 238 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2006 | 192 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3415 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 5044 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2003 | 22 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 218 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1463 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10954 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 174 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 491 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17568 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 924 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2632 | 0.010 |
Why?
|